{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:36:49Z","timestamp":1792784209368,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Allergan, UK"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jtos.2018.11.003","type":"journal-article","created":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T17:58:31Z","timestamp":1541786311000},"page":"9-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"title":["The impact of dry eye disease treatment on patient satisfaction and quality of life: A review"],"prefix":"10.1016","volume":"17","author":[{"given":"Jos\u00e9 A.P.","family":"Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth M.","family":"Santo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jtos.2018.11.003_bib1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.jtos.2018.11.003_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1542-0124(12)70040-X","article-title":"Patient-reported symptoms in dry eye disease","volume":"4","author":"Nichols","year":"2006","journal-title":"Ocul Surf"},{"issue":"5","key":"10.1016\/j.jtos.2018.11.003_bib3","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/ICO.0b013e318225415a","article-title":"Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study","volume":"31","author":"Lemp","year":"2012","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2018.11.003_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11882-013-0403-7","article-title":"Autoimmunity in the pathogenesis and treatment of keratoconjunctivitis sicca","volume":"14","author":"Liu","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"issue":"17","key":"10.1016\/j.jtos.2018.11.003_bib5","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.286.17.2114","article-title":"Hormone replacement therapy and dry eye syndrome","volume":"286","author":"Schaumberg","year":"2001","journal-title":"J Am Med Assoc"},{"issue":"3","key":"10.1016\/j.jtos.2018.11.003_bib6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.jtos.2018.11.003_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/09286580802228509","article-title":"Prevalence of and associated factors for dry eye in a Spanish adult population (the Salnes Eye Study)","volume":"16","author":"Viso","year":"2009","journal-title":"Ophthalmic Epidemiol"},{"issue":"6","key":"10.1016\/j.jtos.2018.11.003_bib8","doi-asserted-by":"crossref","first-page":"e429","DOI":"10.1111\/aos.12174","article-title":"Dry eye disease in French elderly subjects: the Alienor Study","volume":"92","author":"Malet","year":"2014","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2018.11.003_bib9","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/ICO.0b013e318165b1b7","article-title":"Dry eye syndrome in elderly Tibetans at high altitude: a population-based study in China","volume":"27","author":"Lu","year":"2008","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2018.11.003_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/09286580802521317","article-title":"A questionnaire-based assessment of symptoms associated with tear film dysfunction and lid margin disease in an Asian population","volume":"16","author":"Tong","year":"2009","journal-title":"Ophthalmic Epidemiol"},{"issue":"4","key":"10.1016\/j.jtos.2018.11.003_bib11","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ajo.2013.12.023","article-title":"Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life","volume":"157","author":"Paulsen","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2018.11.003_bib12","doi-asserted-by":"crossref","first-page":"781683","DOI":"10.1155\/2014\/781683","article-title":"Aging: a predisposition to dry eyes","volume":"2014","author":"Sharma","year":"2014","journal-title":"J Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtos.2018.11.003_bib13","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1001\/archopht.118.9.1264","article-title":"Prevalence of and risk factors for dry eye syndrome","volume":"118","author":"Moss","year":"2000","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2018.11.003_bib14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ajo.2006.11.060","article-title":"Impact of dry eye syndrome on vision-related quality of life","volume":"143","author":"Miljanovic","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2018.11.003_bib15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II management and therapy report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"},{"issue":"2","key":"10.1016\/j.jtos.2018.11.003_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40135-013-0009-1","article-title":"Dry eye disease: impact on quality of life and vision","volume":"1","author":"Uchino","year":"2013","journal-title":"Curr. Ophthalmol Rep"},{"issue":"2","key":"10.1016\/j.jtos.2018.11.003_bib17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jtos.2015.11.002","article-title":"Economic and humanistic burden of dry eye disease in Europe, north America, and Asia: a systematic literature review","volume":"14","author":"McDonald","year":"2016","journal-title":"Ocul Surf"},{"issue":"5","key":"10.1016\/j.jtos.2018.11.003_bib18","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1185\/03007995.2011.566264","article-title":"Work productivity loss in patients with dry eye disease: an online survey","volume":"27","author":"Patel","year":"2011","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"10.1016\/j.jtos.2018.11.003_bib19","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ajo.2013.10.014","article-title":"Dry eye disease and work productivity loss in visual display users: the Osaka study","volume":"157","author":"Uchino","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2018.11.003_bib20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2147\/CEOR.S36352","article-title":"Impact of dry eye on work productivity","volume":"4","author":"Yamada","year":"2012","journal-title":"Clinicoecon. Outcomes. Res"},{"key":"10.1016\/j.jtos.2018.11.003_bib21","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2147\/OPTH.S99620","article-title":"The association of sleep quality with dry eye disease: the Osaka study","volume":"10","author":"Kawashima","year":"2016","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2018.11.003_bib22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ajo.2013.02.019","article-title":"The impact of dry eye disease on visual performance while driving","volume":"156","author":"Deschamps","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.jtos.2018.11.003_bib23","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/jamaophthalmol.2013.4399","article-title":"Relationship between dry eye symptoms and pain sensitivity","volume":"131","author":"Vehof","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"10.1016\/j.jtos.2018.11.003_bib24","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1167\/iovs.03-0270","article-title":"The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity","volume":"44","author":"Begley","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.jtos.2018.11.003_bib25","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/01.ico.0000133997.07144.9e","article-title":"The lack of association between signs and symptoms in patients with dry eye disease","volume":"23","author":"Nichols","year":"2004","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.jtos.2018.11.003_bib26","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1001\/jamaophthalmol.2013.4503","article-title":"Development and validation of the dry eye-related quality-of-life score questionnaire","volume":"131","author":"Sakane","year":"2013","journal-title":"JAMA ophthalmology"},{"key":"10.1016\/j.jtos.2018.11.003_bib27","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.2147\/OPTH.S89700","article-title":"Associations between signs and symptoms of dry eye disease: a systematic review","volume":"9","author":"Bartlett","year":"2015","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2018.11.003_bib28","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/01.ico.0000154410.99691.3c","article-title":"The agreement between self-assessment and clinician assessment of dry eye severity","volume":"24","author":"Chalmers","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2018.11.003_bib29","series-title":"Cornea E-book","first-page":"387","author":"Mannis","year":"2016"},{"key":"10.1016\/j.jtos.2018.11.003_bib30","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2147\/OPTH.S13773","article-title":"Systane lubricant eye drops in the management of ocular dryness","volume":"5","author":"Benelli","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2018.11.003_bib31","first-page":"157","article-title":"Evaluation of clinical outcomes in patients with dry eye disease using lubricant eye drops containing polyethylene glycol or carboxymethylcellulose","volume":"8","author":"Cohen","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2018.11.003_bib32","first-page":"33","article-title":"Treatment of patients with keratoconjunctivitis sicca with Optive: results of a multicenter, open-label observational study in Germany","volume":"3","author":"Kaercher","year":"2009","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2018.11.003_bib33","doi-asserted-by":"crossref","first-page":"18316","DOI":"10.18535\/jmscr\/v5i3.09","article-title":"A comparative study to evaluate the efficacy of carboxymethylcellulose with glycerin and balanced electrolytes as excipients vs plain carboxymethylcellulose, for keeping the eye moist","volume":"5","author":"Kiran","year":"2017","journal-title":"J Med Sci Clin Res"},{"key":"10.1016\/j.jtos.2018.11.003_bib34","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/bjophthalmol-2016-308608","article-title":"Safety and efficacy of a hydroxypropyl guar\/polyethylene glycol\/propylene glycol-based lubricant eye-drop in patients with dry eye","volume":"101","author":"Labetoulle","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.jtos.2018.11.003_bib35","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/eye.2017.73","article-title":"Osmoprotectants, carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: a randomised controlled trial in moderate to severe dry eye","volume":"31","author":"Labetoulle","year":"2017","journal-title":"Eye"},{"issue":"8","key":"10.1016\/j.jtos.2018.11.003_bib36","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.jcrs.2014.12.056","article-title":"Effect of a hyaluronic acid and carboxymethylcellulose ophthalmic solution on ocular comfort and tear-film instability after cataract surgery","volume":"41","author":"Mencucci","year":"2015","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"10.1016\/j.jtos.2018.11.003_bib37","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/ICO.0b013e31802e1e04","article-title":"Clinical performance of a mid-viscosity artificial tear for dry eye treatment","volume":"26","author":"Simmons","year":"2007","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.jtos.2018.11.003_bib38","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.clinthera.2015.01.001","article-title":"Efficacy, safety, and acceptability of a lipid-based artificial tear formulation: a randomized, controlled, multicenter clinical trial","volume":"37","author":"Simmons","year":"2015","journal-title":"Clin Therapeut"},{"issue":"1","key":"10.1016\/j.jtos.2018.11.003_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5301\/ejo.5000836","article-title":"A randomized, controlled study of the efficacy and safety of a new eyedrop formulation for moderate to severe dry eye syndrome","volume":"27","author":"Chiambaretta","year":"2017","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jtos.2018.11.003_bib40","first-page":"595","article-title":"A randomized crossover study comparing trehalose\/hyaluronate eyedrops and standard treatment: patient satisfaction in the treatment of dry eye syndrome","volume":"11","author":"Pinto-Bonilla","year":"2015","journal-title":"Therapeut Clin Risk Manag"},{"issue":"1","key":"10.1016\/j.jtos.2018.11.003_bib41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/ICL.0000000000000236","article-title":"Efficacy and safety of 0.2% hyaluronic acid in the management of dry eye disease","volume":"43","author":"Pinto-Fraga","year":"2017","journal-title":"Eye Contact Lens"},{"issue":"4","key":"10.1016\/j.jtos.2018.11.003_bib42","first-page":"1055","article-title":"Effectiveness of sodium hyaluronate eye gel in patients with dry eye disease: a multi-centre, open label, uncontrolled study","volume":"29","author":"Saeed","year":"2013","journal-title":"Pak J Med Sci"},{"issue":"6","key":"10.1016\/j.jtos.2018.11.003_bib43","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/jop.1998.14.497","article-title":"The effect of a new tear substitute containing glycerol and hyaluronate on keratoconjunctivitis sicca","volume":"14","author":"Solomon","year":"1998","journal-title":"J Ocul Pharmacol Therapeut"},{"issue":"2","key":"10.1016\/j.jtos.2018.11.003_bib44","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00003226-199603000-00003","article-title":"Hydroxypropyl methylcellulose for the treatment of severe dry eye associated with Sjogren's syndrome","volume":"15","author":"Toda","year":"1996","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2018.11.003_bib45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/bjo.2006.097691","article-title":"Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double-blind, controlled, exploratory study","volume":"91","author":"Prabhasawat","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2018.11.003_bib46","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/jop.2010.0025","article-title":"Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation","volume":"26","author":"Davitt","year":"2010","journal-title":"J Ocul Pharmacol Therapeut"},{"key":"10.1016\/j.jtos.2018.11.003_bib47","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5301\/ejo.5000117","article-title":"Randomized, phase III study comparing osmoprotective carboxymethylcellulose with sodium hyaluronate in dry eye disease","volume":"22","author":"Baudouin","year":"2012","journal-title":"Eur J Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2018.11.003_bib48","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/eye.2010.24","article-title":"The effect of preservative-free HP-Guar on dry eye after phacoemulsification: a flow cytometric study","volume":"24","author":"Sanchez","year":"2010","journal-title":"Eye"},{"key":"10.1016\/j.jtos.2018.11.003_bib49","series-title":"Abstract presented at the 8th International Conference on the Tear Film and Ocular Surface (TFOS), Montpellier, France, 7\u201310 September 2016","article-title":"Clinical outcomes following use of the dual polymer hydroxypropyl guar\/hyaluronic acid-based lubricant eye drops in patients with dry eye","author":"Baudouin","year":"2016"},{"issue":"3","key":"10.1016\/j.jtos.2018.11.003_bib50","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/jop.2008.0026","article-title":"Protecting the ocular surface and improving the quality of life of dry eye patients: a study of the efficacy of an HP-guar containing ocular lubricant in a population of dry eye patients","volume":"25","author":"Rolando","year":"2009","journal-title":"J Ocul Pharmacol Therapeut"},{"issue":"2","key":"10.1016\/j.jtos.2018.11.003_bib51","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1185\/030079905X26252","article-title":"An open-label evaluation of HP-Guar gellable lubricant eye drops for the improvement of dry eye signs and symptoms in a moderate dry eye adult population","volume":"21","author":"Hartstein","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jtos.2018.11.003_bib52","unstructured":"Shimazaki J, Den-Shimazaki S, Masamichi S, Kazumi F, Miki S, Miki I and Takashi O. Presented at the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), Seattle, WA, USA, 1\u20135 May 2016. Abstract 2866\u2013A0075."},{"issue":"10","key":"10.1016\/j.jtos.2018.11.003_bib53","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/bjophthalmol-2011-301448","article-title":"A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients","volume":"96","author":"Takamura","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtos.2018.11.003_bib54","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1097\/OPX.0000000000000657","article-title":"Comparison of topical cyclosporine and diquafosol treatment in dry eye","volume":"92","author":"Yang","year":"2015","journal-title":"Optom Vis Sci"},{"issue":"5","key":"10.1016\/j.jtos.2018.11.003_bib55","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1272\/jnms.82.229","article-title":"Improvements in signs and symptoms of dry eye after instillation of 2% rebamipide","volume":"82","author":"Igarashi","year":"2015","journal-title":"J Nippon Med Sch"},{"issue":"4","key":"10.1016\/j.jtos.2018.11.003_bib56","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.jtos.2018.11.003_bib57","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0161-6420(00)00035-X","article-title":"Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group","volume":"107","author":"Stevenson","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2018.11.003_bib58","first-page":"1","article-title":"Lifitegrast clinical efficacy for treatment of signs and symptoms of dry eye disease across three randomized controlled trials","author":"Holland","year":"2016","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"10.1016\/j.jtos.2018.11.003_bib59","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ophtha.2013.09.015","article-title":"Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study","volume":"121","author":"Sheppard","year":"2014","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.jtos.2018.11.003_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076121","article-title":"Patient reported differences in dry eye disease between men and women: impact, management, and patient satisfaction","volume":"8","author":"Schaumberg","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jtos.2018.11.003_bib61","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-4-79","article-title":"Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance","volume":"4","author":"U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research","year":"2006","journal-title":"Health Qual Life Outcomes"},{"issue":"7","key":"10.1016\/j.jtos.2018.11.003_bib62","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1167\/iovs.16-19419","article-title":"Impact of dry eye disease on work productivity, and patients' satisfaction with over-the-counter dry eye treatments","volume":"57","author":"Nichols","year":"2016","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2018.11.003_bib63","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jtos.2012.01.007","article-title":"Appraisal of patient-reported outcome instruments available for randomized clinical trials in dry eye: revisiting the standards","volume":"10","author":"Guillemin","year":"2012","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2018.11.003_bib64","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1477-7525-9-111","article-title":"Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients","volume":"9","author":"Abetz","year":"2011","journal-title":"Health Qual Life Outcome"},{"issue":"2","key":"10.1016\/j.jtos.2018.11.003_bib65","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/ICO.0000000000000038","article-title":"A review of quality of life measures in dry eye questionnaires","volume":"33","author":"Grubbs","year":"2014","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.jtos.2018.11.003_bib66","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1524-4733.2005.03074.x","article-title":"Comparing the discriminative validity of two generic and one disease-specific health-related quality of life measures in a sample of patients with dry eye","volume":"8","author":"Rajagopalan","year":"2005","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.jtos.2018.11.003_bib67","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/OPX.0b013e3181824e0d","article-title":"Clinically important difference in dry eye: change in IDEEL-symptom bother","volume":"85","author":"Fairchild","year":"2008","journal-title":"Optom Vis Sci"},{"issue":"7","key":"10.1016\/j.jtos.2018.11.003_bib68","first-page":"512","article-title":"Key questions in a dry eye history","volume":"57","author":"McMonnies","year":"1986","journal-title":"J Am Optom Assoc"},{"issue":"4","key":"10.1016\/j.jtos.2018.11.003_bib69","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00003226-200405000-00010","article-title":"The reliability and validity of McMonnies dry eye index","volume":"23","author":"Nichols","year":"2004","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.jtos.2018.11.003_bib70","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the ocular surface disease index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2018.11.003_bib71","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.ophtha.2015.02.037","article-title":"Comparison of two questionnaires for dry eye symptom assessment: the ocular surface disease index and the symptom assessment in dry eye","volume":"122","author":"Amparo","year":"2015","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.jtos.2018.11.003_bib72","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1542-0124(12)70053-8","article-title":"Development and validation of a short global dry eye symptom index","volume":"5","author":"Schaumberg","year":"2007","journal-title":"Ocul Surf"},{"issue":"10","key":"10.1016\/j.jtos.2018.11.003_bib73","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1167\/iovs.06-1253","article-title":"Measurement of ocular surface irritation on a linear interval scale with the ocular comfort index","volume":"48","author":"Johnson","year":"2007","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2018.11.003_bib74","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clae.2009.12.010","article-title":"Validation of the 5-Item Dry Eye Questionnaire (DEQ-5): discrimination across self-assessed severity and aqueous tear deficient dry eye diagnoses","volume":"33","author":"Chalmers","year":"2010","journal-title":"Contact Lens Anterior Eye"},{"issue":"3","key":"10.1016\/j.jtos.2018.11.003_bib75","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II diagnostic methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul Surf"},{"issue":"9","key":"10.1016\/j.jtos.2018.11.003_bib76","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/ICO.0b013e318294b0c0","article-title":"Psychometric properties and validation of the standard patient evaluation of eye dryness questionnaire","volume":"32","author":"Ngo","year":"2013","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2018.11.003_bib77","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00006324-200001000-00012","article-title":"Responses of contact lens wearers to a dry eye survey","volume":"77","author":"Begley","year":"2000","journal-title":"Optom Vis Sci"},{"issue":"5","key":"10.1016\/j.jtos.2018.11.003_bib78","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00003226-200207000-00007","article-title":"The performance of the contact lens dry eye questionnaire as a screening survey for contact lens-related dry eye","volume":"21","author":"Nichols","year":"2002","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.jtos.2018.11.003_bib79","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/OPX.0b013e318269c90d","article-title":"Contact lens dry eye questionnaire-8 (CLDEQ-8) and opinion of contact lens performance","volume":"89","author":"Chalmers","year":"2012","journal-title":"Optom Vis Sci"},{"issue":"11","key":"10.1016\/j.jtos.2018.11.003_bib80","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1001\/archopht.116.11.1496","article-title":"Psychometric properties of the National Eye Institute visual function questionnaire (NEI-VFQ)","volume":"116","author":"Mangione","year":"1998","journal-title":"Arch Ophthalmol"},{"issue":"6846","key":"10.1016\/j.jtos.2018.11.003_bib81","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/bmj.305.6846.160","article-title":"Validating the SF-36 health survey questionnaire: new outcome measure for primary care","volume":"305","author":"Brazier","year":"1992","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.jtos.2018.11.003_bib82","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jtos.2016.04.005","article-title":"Understanding symptoms and quality of life in patients with dry eye syndrome","volume":"14","author":"Barabino","year":"2016","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.jtos.2018.11.003_bib83","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1167\/iovs.03-0915","article-title":"The relative burden of dry eye in patients' lives: comparisons to a US normative sample","volume":"46","author":"Mertzanis","year":"2005","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.jtos.2018.11.003_bib84","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jclinepi.2014.07.009","article-title":"Enhancing the cross-cultural adaptation and validation process: linguistic and psychometric testing of the Brazilian-Portuguese version of a self-report measure for dry eye","volume":"68","author":"Santo","year":"2015","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"10.1016\/j.jtos.2018.11.003_bib85","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/sj.eye.6700169","article-title":"A randomised, crossover, multicentre study to compare the performance of 0.1% (w\/v) sodium hyaluronate with 1.4% (w\/v) polyvinyl alcohol in the alleviation of symptoms associated with dry eye syndrome","volume":"16","author":"McDonald","year":"2002","journal-title":"Eye"},{"issue":"9","key":"10.1016\/j.jtos.2018.11.003_bib86","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/S0161-6420(97)30124-9","article-title":"Efficacy and safety of 0.3% carbomer gel compared to placebo in patients with moderate-to-severe dry eye syndrome","volume":"104","author":"Sullivan","year":"1997","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.jtos.2018.11.003_bib87","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12886-016-0343-9","article-title":"Efficacy of a fixed combination of 0.09% xanthan gum\/0.1% chondroitin sulfate preservative free vs polyethylene glycol\/propylene glycol in subjects with dry eye disease: a multicenter randomized controlled trial","volume":"16","author":"P\u00e9rez-Balbuena","year":"2016","journal-title":"BMC Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2018.11.003_bib88","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/01.opx.0000171818.01353.8c","article-title":"The effect of two novel lubricant eye drops on tear film lipid layer thickness in subjects with dry eye symptoms","volume":"82","author":"Korb","year":"2005","journal-title":"Optom Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2018.11.003_bib89","first-page":"61","article-title":"Report of the international dry eye Workshop (DEWS)","volume":"5","author":"International Dry Eye Workshop","year":"2007","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.jtos.2018.11.003_bib90","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jtos.2013.07.003","article-title":"Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting","volume":"11","author":"Baudouin","year":"2013","journal-title":"Ocul Surf"},{"issue":"7","key":"10.1016\/j.jtos.2018.11.003_bib91","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3109\/02713683.2014.957776","article-title":"Effects of l-Carnitine, Erythritol and Betaine on pro-inflammatory markers in primary human corneal epithelial cells exposed to hyperosmotic stress","volume":"40","author":"Hua","year":"2015","journal-title":"Curr Eye Res"},{"issue":"3","key":"10.1016\/j.jtos.2018.11.003_bib92","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s12016-014-8438-7","article-title":"Current approach to dry eye disease","volume":"49","author":"Valim","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"10.1016\/j.jtos.2018.11.003_bib93","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2147\/OPTH.S1409","article-title":"Treatment of chronic dry eye: focus on cyclosporine","volume":"2","author":"Kymionis","year":"2008","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2018.11.003_bib94","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12886-015-0122-z","article-title":"Expert opinion in the management of aqueous deficient dry eye disease (DED)","volume":"15","author":"Sy","year":"2015","journal-title":"BMC Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2018.11.003_bib95","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/ICO.0b013e31823f8c9b","article-title":"Clinical treatment of dry eye using 0.03% tacrolimus eye drops","volume":"31","author":"Moscovici","year":"2012","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.jtos.2018.11.003_bib96","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.clae.2015.04.004","article-title":"Treatment of Sjogren's syndrome dry eye using 0.03% tacrolimus eye drop: prospective double-blind randomized study","volume":"38","author":"Moscovici","year":"2015","journal-title":"Contact Lens Anterior Eye"},{"issue":"4","key":"10.1016\/j.jtos.2018.11.003_bib97","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/ICU.0b013e32833a8c15","article-title":"Impact of dry eye disease and treatment on quality of life","volume":"21","author":"Friedman","year":"2010","journal-title":"Curr Opin Ophthalmol"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154201241830034X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154201241830034X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:35:16Z","timestamp":1761539716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154201241830034X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S154201241830034X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2018.11.003","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of dry eye disease treatment on patient satisfaction and quality of life: A review","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2018.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}